Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

In acute infective exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (COPD), adding erdosteine to standard treatment significantly modified the outcome by improving the ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can ... system uses symptoms and exacerbations to grade the severity ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks ... the way for new treatment ... Zinc Deficiency Promotes Acinetobacter Lung Infection, Study Finds ...

In the phase 3 ENHANCE trials, Ohtuvayre was shown to reduce exacerbation rate and risk ... anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures ...

which would make them suitable for treatment with Nucala. Elevated eosinophil levels are associated with more severe COPD and a higher rate of exacerbations, the sudden flare-ups in symptoms that ...

Injurious falls are common among people with COPD in the 2 years before death, with some medications tied to higher fall risk.

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms of asthma. At the time of the attack, the treatment consists of an injection ...